Donation

As the COVID-19 respiratory virus spreads, please know that the IMF is here for you.

Featured are Dr. Durie’s blogs and FAQs, aimed specifically at multiple myeloma patients, and links to the best sources of COVID-19 news.

 

On Thursday, December 23, 2021, The FDA authorized two oral antiviral treatments for COVID-19: Molnupiravir and Paxlovid. Molnupiravir is for adults who are vulnerable to becoming severely ill from COVID-19 and for whom alternative COVID-19 treatment options authorized by the FDA are “not accessible or clinically appropriate,” according to the New York Times. The treatment is expected to be available in a few weeks. The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness, according to a report in the New York Times, which adds that the treatment for high-risk patients 12 and older could be available within a few days.

On Monday, November 29, 2021, the World Health Organization (WHO) called the risks posed by the new omicron variant of the coronavirus, B.1.1.529, “very high,” the New York Times reports. The variant’s number of mutations — including up to 32 variations in the spike protein — means that there could be future surges of Covid-19.

While the variant may be more transmissible than prior versions of the virus, experts say existing vaccines are likely to offer protection from severe illness and death. Researchers await new data to understand more about B.1.1.529.

In the meantime, the CDC has issued a statement on omicron recommending that people follow these prevention strategies:

  • Wear a mask in public indoor settings in areas of substantial or high community transmission
  • Wash your hands frequently
  • Physically distance from others
  • Protect yourself from COVID-19 by getting fully vaccinated (everyone 5 years and older)
  • Get a COVID-19 vaccine booster dose if you are eligible

Please be safe and well, and please contact the IMF InfoLine with any questions

covid 19 vaccine vials
COVID-19 Vaccination and Myeloma Patients

Read this page for the IMF’s latest recommendations on receiving the COVID-19 vaccine if you have multiple myeloma (MM), smoldering multiple myeloma (SMM), or monoclonal gammopathy of undetermined significance (MGUS). 

a
Image Right
White
FDA approval stamp
FDA Authorizes Second Oral Antiviral Treatments for COVID-19

On December 23, 2021, the FDA has authorized the second oral antiviral treatment of COVID-19. Molnupiravir is for adults who are vulnerable to becoming severely ill from COVID and for whom alternative COVID treatment options authorized by the FDA are “not accessible or clinically appropriate,” according to the New York Times. The treatment is expected to be available in a few weeks.

a
Image Left
White
IMF Videos and News on COVID-19
Ask Dr Durie Covid-19 FAQs

#ASKDRDURIE COVID-19 FAQs

As the COVID-19 respiratory virus spreads across the country and around the world, myeloma patient safety is a paramount concern of patients, families and caregivers. 

Watch Dr. Durie's COVID-19 FAQ video series to learn more how COVID-19 has affected the myeloma community.

Dr. Brian G.M. Durie talks about MGUS and COVID-19
From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF Videos are your all-access ticket to critical myeloma research, patient education, and guidance. Check back often for updated content.
Should myeloma patients alter their treatment before getting vaccinated against covid-19?
From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF Videos are your all-access ticket to critical myeloma research, patient education, and guidance. Check back often for updated content.
Will upcoming medications against Covid-19 be useful for myeloma patients?
From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF Videos are your all-access ticket to critical myeloma research, patient education, and guidance. Check back often for updated content.
Rev3 CoronaVirus
From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF Videos are your all-access ticket to critical myeloma research, patient education, and guidance. Check back often for updated content.
cover image for COVID-19 guidance
From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF Videos are your all-access ticket to critical myeloma research, patient education, and guidance. Check back often for updated content.
Covid-19 for Support Group Leaders
From our weekly series “Ask Dr. Durie” to comprehensive news from key cancer medical conferences around the world, IMF Videos are your all-access ticket to critical myeloma research, patient education, and guidance. Check back often for updated content.
Gavel and Stethoscope
Federal Government Response to COVID-19

We wanted to take some time and keep you up to date on the Federal Government’s response regarding COVID-19. We have received a lot of questions from patients and their families about what is included in the government has done to address the virus. 

a
Image Left
White

COVID-19 External Resources:

Pharma Resources:



The International Myeloma Foundation medical and editorial content team

Comprised of leading medical researchers, hematologist, oncologists, oncology-certified nurses, medical editors, and medical journalists, our team has extensive knowledge of the multiple myeloma treatment and care landscape. Additionally, Dr. Brian G.M. Durie reviews and approves all medical content on this website.

Last Medical Review: January 12, 2021

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.